Posted on 8/13/18
Neurotrope Provides Business Update
Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today provided a business update outlining recent clinical . . .
Posted on 8/13/18
Provention Bio Reports Second Quarter 2018 Financial Results and Provides Business Update
Recent Corporate Highlights: Closed initial public offering of common stock on July 19, 2018, generating $63.9 million in gross proceedsExpanded pipeline with two additional clinical-stage assets . . .
Posted on 8/13/18
Vitamin Shoppe: Cognitive Dissonance And Why We Got Short When Shares Crossed $11
SummaryVitamin Shoppe's stock is on a tear after posting better than feared Q2 2018 results, but this just feels like a short squeeze.Adjusted for Nutri-Force moving . . .
Posted on 8/13/18
Why Celgene Corporation Bounced Back in July
What happenedAfter a prolonged losing streak, Celgene Corporation's (NASDAQ:CELG) stock rebounded quite nicely last month by gaining 13.4%, according to data from S&P Global Market Intelligence. . . .
Posted on 8/12/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 6, 2018 it approved non-statutory stock options to purchase an aggregate of 170,200 shares of its . . .
Posted on 8/10/18
Matinas BioPharma Provides Corporate Update
BEDMINSTER, N.J., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of . . .
Posted on 8/10/18
ADMA Biologics Reports Second Quarter 2018 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) today announced its financial results for the quarter ended . . .
Posted on 8/10/18
Kadmon Provides Business Update
NEW YORK--(BUSINESS WIRE)--Kadmon Holdings, Inc. (NYSE:KDMN) today provided a business update and reported financial and operational results for the second quarter of 2018.“Kadmon continues to build . . .
Posted on 8/10/18
Spring Bank Prices Public Offering of Common Stock
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced the pricing of an underwritten public offering . . .
Posted on 8/10/18
Vaccinex Announces Pricing of Initial Public Offering
ROCHESTER, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Vaccinex), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat . . .
Posted on 8/9/18
Citius Announces Pricing of $10.0 Million Underwritten Offering
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the pricing of an underwritten . . .
Posted on 8/8/18
Spring Bank Announces Proposed Public Offering of Common Stock
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced that it intends to offer and sell, . . .
Posted on 8/8/18
Celldex Provides Corporate Update and Reports Q2 2018 Results
HAMPTON, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2018. . . .
Posted on 8/8/18
MeiraGTx Reports Q2 2018 Financial Results and Provides Corporate Update
LONDON and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results . . .
Posted on 8/8/18
Champions Oncology Granted Full Accreditation by the AAALAC
Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced . . .
Posted on 8/8/18
Axsome Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system . . .
Posted on 8/8/18
Johnson & Johnson: Headline Risk But Business Solid
SummaryWe remain big fans of the steady hand displayed by the venerable Johnson & Johnson as the pharmaceutical bellwether continues to perform admirably.During its second-quarter results, . . .
Posted on 8/8/18
Pfizer: The Outlook Cannot Justify Current Valuation
SummaryPfizer is currently trading at a ~20% discount rate, when taking into account discounted cash flows as well as a multiples analysis.Current estimates of a -5% . . .
Posted on 8/7/18
TG Therapeutics Provides Business Update
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended June 30, 2018 . . .
Posted on 8/7/18
Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that it is offering to sell shares of its common stock . . .
Posted on 8/7/18
Eagle Pharmaceuticals Reports Second Quarter 2018 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three and six months ended June 30, 2018. Highlights of and subsequent . . .
Posted on 8/7/18
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
NEW HAVEN, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious . . .
Posted on 8/17/18
Interview with Paula Swain, EVP of Human Resources at Incyte Corporation - Part III
Brought to you by Newmark Knight Frank
Posted on 8/7/18
Why Pfizer Stock Gained 10% in July
What happenedPfizer (NYSE:PFE) stock outpaced the market last month, gaining 10% compared to a 3.6% increase in the S&P 500, according to data provided by S&P . . .
Posted on 8/7/18
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
EDISON, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the . . .

